JPX · EQUITY · ENHANCED MARKET DYNAMICS
4883
Modalis Therapeutics CorporationJP · Healthcare · Drug Manufacturers - Specialty & Generic
CURRENT COMPLETED-WEEK READ
Cautious
The balance of evidence is weakening and risk control deserves more attention. Conditions remain cautious, although the latest readings are improving.
- Completed week
- 28 Aug 2026
- Latest close
- JPY 33.00
- Evidence
- 156 weeks
COMPLETED-WEEK OVERVIEW
Price and market conditions over time
1 supportive · 3 cautious
THE FULL PRICE CYCLE
Follow the journey from one zone to the other
Each state uses completed-week information available at that point.
Lower zone
Price establishes residence near the bottom of its long-cycle range. Improving EMD separates early repair from continued deterioration.
Upward journey
Price leaves the lower zone while EMD confirms improving participation. The objective is the broader move toward the upper zone, not a short weekly trade.
Upper zone
Price establishes residence near the top of its long-cycle range. This is the profit-harvest area, with EMD watched for exhaustion and loss of support.
Downward journey
Price leaves the upper zone while EMD weakens. The reverse cycle remains active until lower-zone residence is confirmed again.
CURRENT READINGS
What the latest week shows
Completed-week values
01
Underlying pressure
Cautious pressure beneath price
4-week change +0.17
02
Trend and deviation
Price structure is below its trend baseline
Trend gate inactive
03
Momentum and SMI
Momentum is applying downside pressure
SMI 0.04
04
Price-volume pressure
Volume is confirming the close
Volume ratio 1.38x
05
Relative leadership
The ticker is lagging its benchmark
4-week change +7.47
06
Modeled Trend
Modeled Trend is supportive
Smoothed Modeled Trend 0.11